| Name | 4-[(5-bromopyridin-2-yl)methyl]morpholine |
|---|---|
| Synonyms |
Morpholine, 4-[(5-bromo-2-pyridinyl)methyl]-
4-(5-bromo-pyridin-2-ylmethyl)-morpholine 5-bromo-2-(4-morpholinylmethyl)pyridine 4-[(5-Bromo-2-pyridinyl)methyl]morpholine 4-[(5-bromo-2-pyridinyl) methyl]morpholine |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 310.8±37.0 °C at 760 mmHg |
| Molecular Formula | C10H13BrN2O |
| Molecular Weight | 257.127 |
| Flash Point | 141.7±26.5 °C |
| Exact Mass | 256.021118 |
| PSA | 25.36000 |
| LogP | 0.71 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.579 |
|
~85%
294851-95-9 |
| Literature: LOCUS PHARMACEUTICALS, INC. Patent: US2010/41642 A1, 2010 ; Location in patent: Page/Page column 21 ; |
|
~28%
294851-95-9 |
| Literature: PROLYSIS LTD Patent: WO2009/74812 A1, 2009 ; Location in patent: Page/Page column 77 ; WO 2009/074812 A1 |
|
~62%
294851-95-9 |
| Literature: Boehringer Ingelheim Pharmaceuticals, Inc. Patent: US6822093 B2, 2004 ; |
| Precursor 5 | |
|---|---|
| DownStream 1 | |